Insulet Corp: Form 10-Q for the period ended Sep 30, 2011
Filed with the SEC on Nov 8, 2011 and accepted by EDGAR at Nov 8, 2011, 21:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2011-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2011-07-01 to 2011-09-30 | $44.6m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-01-01 to 2011-09-30 | $105.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2011-07-01 to 2011-09-30 | $26.0m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2011-01-01 to 2011-09-30 | $58.4m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2011-07-01 to 2011-09-30 | $18.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2011-01-01 to 2011-09-30 | $46.6m | us-gaap:GrossProfit |
| Research and development | 3 months2011-07-01 to 2011-09-30 | $4.6m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2011-01-01 to 2011-09-30 | $16.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2011-07-01 to 2011-09-30 | −$9.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-01-01 to 2011-09-30 | −$32.0m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2011-07-01 to 2011-09-30 | −$13.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2011-01-01 to 2011-09-30 | −$42.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2011-07-01 to 2011-09-30 | −$0.29 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2011-01-01 to 2011-09-30 | −$0.92 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2011-01-01 to 2011-09-30 | −$17.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2011-01-01 to 2011-09-30 | $8.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2011-09-30 | $103.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2011-09-30 | $137.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2011-09-30 | $215.8m | us-gaap:Assets |
| Current liabilities | At period end2011-09-30 | $24.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2011-09-30 | $132.3m | us-gaap:Liabilities |
| Shareholders' equity | At period end2011-09-30 | $83.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950123-11-096474. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.